Providence Ordered to Pay $200M for ‘Systemic Wage Violations’
More than 33,000 Providence employees filed a class-action complaint against the health system in 2021, alleging that it had been withholding their wages by denying them breaks and rounding down their working hours. Last week, Providence was ordered to pay more than $200 million in damages — a decision that “sends a message to healthcare corporations,” according to an attorney representing the workers.
FDA Drug Approval Marks a New Day for Treating Pediatric Brain Cancer
Day One Biopharmaceuticals drug Ojemda is now FDA-approved for advanced pediatric low-grade glioma, the most common type of brain cancer in children. The regulatory decision for Ojemda covers a broader swath of patients than a drug combination from Novartis approved for treating this childhood cancer.
It’s Time to Give Patients a Seat at the Table
Game-changing advances can be achieved by integrating patient collaboration and priorities into the full span of trial design.
To Further Impede the Progression of Heart Disease, We Must Treat Patients With Anti-Inflammatory Drugs in Combination With Statin Therapy
it is paramount that we address both cholesterol risk and inflammation to reduce the risk of a heart attack or stroke.
FTC Chief Says Tech Advancements Risk Healthcare Price Fixing
Algorithms make it possible for companies to fix prices without explicitly coordinating with one another, posing a new test for regulators policing the market, said Lina Khan, chair of the Federal Trade Commission, during a media event hosted by KFF.